CardioFocus HeartLight Post-Approval Study

Launched by CARDIOFOCUS · May 25, 2017

Keywords

ClinConnect Summary

The CardioFocus HeartLight Post-Approval Study is looking to learn more about the outcomes of patients with a heart condition called atrial fibrillation after they have been treated with a device called the HeartLight System. This study is important because it will help confirm the positive results seen in earlier research about this treatment. The trial is currently recruiting participants who are 18 years or older and have been experiencing symptoms from their atrial fibrillation. To be eligible, participants must have tried at least one medication to help with their condition but found it ineffective.

If you or someone you know is considering participating, it’s good to know that the study is open to everyone, regardless of gender, and is specifically for those who are planning to undergo a procedure called catheter ablation. This procedure aims to correct the irregular heartbeats caused by atrial fibrillation. Participants will be monitored closely to see how well the HeartLight System works in real-world settings. Overall, this study is an opportunity for patients to contribute to important research that could enhance treatment options for atrial fibrillation in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years or older
• • planned for catheter ablation due to symptomatic paroxysmal atrial fibrillation
• • failure of at least one anti-arrhythmic drug
• • others
• Exclusion Criteria:
• • overall good health as established by multiple criteria